Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Apr 10.
Published in final edited form as: Inorg Chem. 2023 Mar 27;62(14):5315–5319. doi: 10.1021/acs.inorgchem.3c00342

Active site structures of the E. coli N-hydroxylaminopurine resistance molybdoenzyme YcbX

Jing Yang 1,, Michel Struwe 2,3,, Axel Scheidig 2, Joshua Mengell 1, Bernd Clement 3, Martin L Kirk 1
PMCID: PMC10544827  NIHMSID: NIHMS1931984  PMID: 36971376

Abstract

X-ray absorption near-edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) data have been used to characterize the coordination environment for the catalytic Mo site of E.coli YcbX in two different oxidation states. In the oxidized state, the Mo(VI) ion is coordinated by two terminal oxo ligands, a thiolate S from cysteine, and two sulfur donors from the bidentate pyranopterin ene-1,2-dithiolate (pyranopterin dithiolene; PDT). Upon reduction, it is the more basic equatorial oxo ligand that is protonated, with a Mo-Oeq bond distance that is best described as either a short Mo4+-OH2 bond or a long Mo4+-OH bond. Mechanistic implications for substrate reduction are discussed in light of these structural details.

Graphical Abstract

graphic file with name nihms-1931984-f0004.jpg


Pyranopterin molybdenum enzymes are typically characterized as belonging to either the sulfite oxidase (SO), xanthine oxidase (XO), or dimethyl sulfoxide reductase (DMSOR) enzyme families.15 However, the molybdenum cofactor sulfurase C-terminal (MOSC) domain enzymes611 represent a new family of molybdenum enzymes that do not possess any detectable homology with the original three canonical molybdenum enzyme families, although the MOSC domain proteins appear to possess active site structures that are reminiscent of SO family enzymes. However, a key difference between MOSC domain enzymes and SO family enzymes is that the latter frequently fuse to cytochromes and do not have the [2Fe-2S] ferredoxin domains commonly seen in either MOSC (e.g., the bacterial YcbX and YiiM proteins) or XO family enzymes. The YcbX MOSC enzymes12 are of intense interest since they are orthologues of the eukaryotic mitochondrial amidoxime reducing component (mARC) enzymes,68, 1320 which are mostly represented by two paralogues, mARC1 and mARC2. The mARCs are biotransformation and moonlighting enzymes6, 13 that can reduce highly toxic or mutagenic N-oxygenated metabolites (Figure 1), which derive from the catalytic action of cytochrome P450s or flavin dependent monooxy-genases. Although the exact biological roles for mARC enzymes remain undetermined, YcbX and YiiM catalyze the reduction of N-hydroxylated purines to protect E. coli from the mutagenic and toxic effects of these compounds.12, 21 Catalytic electrochemistry studies show that YcbX is specific for N-hydroxylated substrates and does not catalytically reduce N-oxides.22 This substrate specificity indicates important differences in active site structure relative to other pyranopterin Mo enzymes, contributing to their respective reactivity profiles.

Figure 1.

Figure 1.

Proposed mechanism of substrate reduction by MOSC family enzymes, including YcbX. Note that the Mo(VI) → Mo(IV) reduction step is expected to proceed via an obligatory Mo(V) intermediate.

The eukaryotic mARC enzymes are small monomeric proteins that do not contain prosthetic groups other than the pyranopterin dithiolene (PDT, also known as molybdopterin; MPT), but their bacterial counterparts are multidomain proteins with additional redox-active prosthetic groups. For example, E. coli YcbX binds both Mo-(MPT) and a [2Fe2S] cluster in addition to forming homodimers. Unfortunately, no crystal structure of E. coli YcbX has been published and no spectroscopic data on the molybdenum active site are available, further complicating the development of structure-property relationships among MOSC family enzymes. The only MOSC domain protein crystal structures are those of human mARC17 and its disease-related p.A165T variant.23 However, in these structures there is only partial occupancy of the Mo ion and the exact coordination environment about the Mo ion is not clearly defined. The structure of plant mARC1 in the oxidized Mo(VI) state has been interrogated by X-ray absorption spectroscopy (XAS).8 Using extended X-ray absorption fine structure (EXAFS), the active site coordination environment was observed to be similar to that of SO with the Mo ion being coordinated by the two S atoms of the PDT, a S atom from a conserved cysteine thiolate, and two terminal oxo ligands.8 Interestingly, there is no detectable similarity between the amino acid sequences or the protein folds of these MOSC enzymes and SO, despite their apparent active site structural similarity.

Although MOSC domain proteins are very highly abundant in nature, we know remarkably little about their protein and Mo active site structures. Here, we examine the first coordination sphere environment of the catalytic Mo ion in YcbX as a function of oxidation state and sample preparation using X-ray absorption near-edge structure (XANES) spectroscopy and EXAFS. The Mo K-edge XANES spectra for as-isolated, excess substrate oxidized, and dithionite-reduced E. coli YcbX are presented in Figure 2. The rising edge energies, determined by using the first derivative inflection point, are observed at 20016.2 eV (oxidized), 20015.4 eV (as-isolated), and 20012.5 eV (reduced) and these energies reflect Mo oxidation state and effective nuclear charge differences between the different enzyme forms. Further inspection of the data in Figure 2 shows that the as-isolated (Figure 2, blue) and excess substrate oxidized (Figure 2, red) enzyme XANES are slightly different. The fully oxidized Mo(VI) enzyme sample was obtained from the as-isolated protein by reacting it with excess substrate, benzamidoxime. Enzyme that has been reduced with dithionite displays a markedly different XANES spectrum (Figure 2, green). All three of the YcbX XANES spectra shown in Figure 2 display a typical “oxo-edge” transition in the pre-edge region at 20004.5 eV (oxidized), 20003.7 eV (as-isolated), and 20003.3 eV (reduced). The intensity of this “oxo-edge” pre-edge feature can be correlated with the number of terminal oxo ligands that are covalently bound to the metal ion.8, 2426 Thus, the increased intensity of this feature in the oxidized and as-isolated data sets clearly indicates a greater number of terminal oxo ligands bound to Mo in these enzyme forms when compared to the reduced enzyme form.

Figure 2.

Figure 2.

Mo K-edge XANES spectra for E. coli YcbX as a function of oxidation state and sample preparation.

The EXAFS data (k-range 3-12 Å−1) for oxidized and reduced YcbX are presented in Figure 3 and summarized in Table S1. The data clearly indicate that both Ooxo and S donor shells dominate the first coordination sphere of the Mo ion in the YcbX active site. For the oxidized species, the best fit to the EXAFS data yields a di-oxo site with Mo6+-Ooxo bond distances of 1.730 Å and three sulfur donors with Mo6+-S bond distances of 2.445 Å. These bond distances are very similar to those determined for the oxidized active sites of sulfite oxidase family enzymes2730 and plant mARC18 (pmARC1). For the reduced YcbX enzyme form, the Mo(IV) ion is found to be coordinated by a single terminal oxo ligand (Mo4+-Ooxo = 1.707 Å), three S donors with Mo4+-S bond distances of 2.406 Å, and a non-oxo light atom at 2.194 Å. To investigate the possibility that Scys has de-coordinated from the Mo(IV) site, we performed a bond valence sum (BVS) analysis31, 32 using the reduced YcbX EXAFS data. This analysis yields a BVS of 3.96, which is in excellent agreement with the Mo(IV) oxidation state assignment and is fully consistent with SCys remaining coordinated to Mo in reduced enzyme. The non-oxo light atom donor is generally accepted to be a water molecule in reduced forms of SO,28 plant nitrate reductase (pNR),33 and the C-terminal domain of the MOSC protein human molybdenum cofactor sulfurase (HMCS-CT).8 In these enzymes, the EXAFS determined non-oxo Mo4+-O bond distances vary by 0.31Å (2.30 Å, SO;28 2.18 Å, pNR;33 2.49 Å, HMCS-CT8). The non-oxo bond distance in XO is markedly shorter34 at 1.98 Å and has been assigned as arising from Mo4+-OH.35 DFT results for computational models of reduced SO result in 2.08 Å and 2.34 Å bond lengths for Mo4+-OH and Mo4+-OH2, respectively.28 However, there is some degree of uncertainty in these non-oxo Mo4+-O bond lengths due to the partially in-phase relationship between the weaker Mo4+-O EXAFS oscillations and the markedly more intense Mo4+-S EXAFS.34 Thus, given the 2.194 Å Mo4+-O bond length determined for reduced YcbX, we attribute this to be either a short Mo4+-OH2 bond or a long Mo4+-OH bond.34 The crystal structure of the related human mARC1 shows that this equatorial ligand is oriented directly toward the solvent, and is therefore likely involved in catalysis.7 If the active site structure of reduced YcbX is [(PDT)MoIVO(SCys)(OH)]2−, with a hydroxide ligand coordinated to Mo(IV), this would have interesting consequences for the mechanism of substrate reduction since the coordinated hydroxide would have to be protonated, perhaps by the substrate, to allow for water labilization and binding of the activated anionic substrate (Figure 1).

Figure 3.

Figure 3.

Mo K-edge EXAFS data for oxidized (A, D), as-isolated (B, E), and reduced (C, F) E. coli YcbX.

Close inspection of the EXAFS oscillations for the as-isolated enzyme (Figure 3, B and E) indicates that this preparation closely resembles the oxidized form (Figure 3, A and D). The slight differences between the oxidized and as-isolated samples can be explained by as-isolated being a mixture of oxidized and reduced forms. This is supported by the presence of the more pronounced EXAFS feature at ~4 Å−1 in as-isolated, which clearly shows that some of the reduced enzyme form is also present. We have used a linear combination fit to show that the as-isolated sample is a mixture comprised of 88.5% oxidized and 11.5% reduced enzyme forms (Figure S1). Thus, the heterogeneity we observe in the as-isolated enzyme does not appear to derive from an inhibited or otherwise catalytically inactive species, indicating that the as-isolated enzyme is fully active. The observation that as-isolated YcbX is a mixture of oxidized and reduced enzyme forms is of interest, since pyranopterin Mo enzymes are usually obtained in the fully oxidized Mo(VI) state after aerobic purification.27, 36, 37

Regarding the active site heterogeneity observed for SO family enzymes, EXAFS has been used to show that plant nitrate reductase (pNR) possess two different Mo(VI) forms.33 Although the EXAFS data for oxidized as-isolated enzyme and as-isolated enzyme incubated with excess nitrite or nitrate are virtually identical, the addition of nitrate to reduced pNR leads to changes in the Fourier transform intensity ratios of the Mo≡O and Mo-S EXAFS peaks. Analysis of the EXAFS data indicates one of the Mo-Sditholene bonds is elongated in oxidized as-isolated enzyme, with the nitrate-oxidized species possessing a catalytically relevant [(PDT)MoO2(SCys)]1− active site with three equivalent Mo-S bonds. Interestingly, the nitrate-oxidized form reverts to the as-isolated form following gel filtration.33 For the related SO family protein MsrP (formally known as YedY) the as-isolated form is an inhibited Mo(V) species with an equatorial thiol ligand replacing the H2O/OH.38 In marked contrast, the active site heterogeneity that we observe here for YcbX is completely unrelated to these cases since simple incubation of as-isolated enzyme with substrate leads to a homogeneous Mo(VI) oxidized enzyme form. Furthermore, reduction with dithionite produces a similarly homogeneous reduced Mo(IV) species. The as-isolated protein does not contain any relevant Mo(V) species that are detectable by EPR spectroscopy. Thus, our enzyme preparations appear to contain intact, fully active protein in a mixture of two oxidation states. It is assumed that recombinant YcbX is reduced by its electron transfer partner CysJ in E. coli cells. In absence of substrate, the enzyme remains in this state due to the low redox potential within the E. coli cytosol. We hypothesize that when the cells are lysed and the protein isolated, the enzyme is apparently not completely oxidized by air, leading to the mixed Mo(IV)/Mo(VI) as-isolated state.

In summary, this is the first study in which the active site Mo coordination environment of a MOSC domain protein has been examined by EXAFS in both its reduced Mo(IV) and oxidized Mo(VI) forms for direct comparison with canonical SO family enzymes. While the structure of the YcbX Mo(VI) state is very similar to that of SO3943 and plant nitrate reductase (pNR),44 there may exist subtle but important aspects of the Mo coordination sphere that contribute to their different reactivities.2, 45 , 46 Although there is no definitive experimental evidence for a direct oxygen atom transfer mechanism in SO or pNR,1 this is the generally accepted mechanism and is supported by spectroscopic47 and reaction coordinate computations.2, 14, 4850 Key to this reactivity in SO is the electronic structure-induced activation of the equatorial oxo ligand for bond scission upon two-electron transfer from the substrate to a Mo=Ooxo d-p π* orbital.47 The mechanism for pNR is proposed to be the reverse of that in SO, requiring the loss of a labile water ligand in reduced pNR to allow for direct binding of nitrate to Mo(IV) to initiate the oxygen atom transfer reaction. A thermodynamic basis for the differences in SO and pNR reactivity is related to the relative bond enthalpies for the substrate S=O and N=O bonds, and the Mo=O/Mo≡O bonds of the catalytic site.51 Additional studies of the reduced Mo(IV) state in YcbX are ongoing in order to confirm the nature of the second oxygen ligand as either a water or hydroxide, with a key emphasis on how this ligand and the nature of bound substrate contribute to the mechanism of substrate reduction by YcbX and related mARC family enzymes.

Supplementary Material

Supporting Information

SYNOPSIS TOC.

X-ray absorption spectroscopy has been used to structurally characterize the oxidized and reduced forms of the MOlybdenum Sulfurase C-terminal (MOSC) domain protein YcbX. In the oxidized state, the Mo(VI) ion is coordinated by two terminal oxo ligands, a thiolate S from cysteine, and two sulfur donors from the pyranopterin dithiolene (PDT) ligand. In the reduced form of the enzyme, the Mo-Oeq bond distance is best described as either a short Mo4+-OH2 bond or a long Mo4+-OH bond with mechanistic implications for substrate reduction.

ACKNOWLEDGMENT

M. L. K. acknowledges the National Institutes of Health (GM-057378) for continued financial support of our work on molybdoenzymes. M. L. K and J. Y. acknowledge the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, which is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. M.A.S. received a PhD scholarship from the German Academic Scholarship Foundation and is an Add-On Fellow of the Joachim Herz Foundation. We also thank The University of New Mexico Center for Advanced Research Computing, supported in part by the National Science Foundation, for providing high-performance computing resources used in this work.

Funding Sources

No competing financial interests have been declared.

Footnotes

Supporting Information. Enzyme preparation, purification, and characterization; details regarding XAS experiments; selected results of fitting to EXAFS data; details on computational and bond valence sum studies; atomic coordinates (file type PDF). The Supporting Information is available free of charge on the ACS Publications website.

REFERENCES

  • (1).Hille R; Hall J; Basu P The Mononuclear Molybdenum Enzymes. Chemical Reviews 2014, 114 (7), 3963–4038. DOI: 10.1021/cr400443z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Ingersol LJ; Kirk ML Structure, Function, and Mechanism of Pyranopterin Molybdenum and Tungsten Enzymes. In Comprehensive Coordination Chemistry III, Constable EC, Parkin G, Que L Jr Eds.; Elsevier, 2021; pp 790–811. [Google Scholar]
  • (3).Kirk ML; Kc K Molybdenum and Tungsten Cofactors and the Reactions They Catalyze Transition Metals and Sulfur – A Strong Relationship for Life. In Metal Ions in Life Sciences, Sosa Torres M, Kroneck P Eds.; Vol. 20; De Gruyter, 2020; pp 313–342. [Google Scholar]
  • (4).Kirk ML Spectroscopic and Electronic Structure Studies of Mo Model Compounds and Enzymes. In Molybdenum and Tungsten Enzymes: Spectroscopic and Theoretical Investigations, Hille R, Schulzke C, Kirk ML, Eds.; The Royal Society of Chemistry: Cambridge, UK, 2017; pp 13–67. [Google Scholar]
  • (5).Hille R; Schulzke C; Kirk ML Molybdenum and Tungsten Enzymes. In RSC Metallobiology Series, Garner CD, Sun H, Wedd A, Ciurli SL, Eds.; The Royal Society of Chemistry: Cambridge, UK, 2017. [Google Scholar]
  • (6).Tejada-Jimenez M; Chamizo-Ampudia A; Calatrava V; Galvan A; Fernandez E; Llamas A From the Eukaryotic Molybdenum Cofactor Biosynthesis to the Moonlighting Enzyme mARC. Molecules 2018, 23 (12). DOI: 10.3390/molecules23123287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Kubitza C; Bittner F; Ginsel C; Havemeyer A; Clement B; Scheidig AJ Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes. Proceedings of the National Academy of Sciences 2018, 115 (47), 11958–11963. DOI: 10.1073/pnas.1808576115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Giles LJ; Ruppelt C; Yang J; Mendel RR; Bittner F; Kirk ML Molybdenum Site Structure of MOSC Family Proteins. Inorg. Chem 2014, 53 (18), 9460–9462. DOI: 10.1021/ic5015863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Neve EPA; Nordling A; Andersson TB; Hellman U; Diczfalusy U; Johansson I; Ingelman-Sundberg M Amidoxime Reductase System Containing Cytochrome b(5) Type B (CYB5B) and MOSC2 Is of Importance for Lipid Synthesis in Adipocyte Mitochondria. J. Biol. Chem 2012, 287, 6307–6317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Wahl B; Reichmann D; Niks D; Krompholz N; Havemeyer A; Clement B; Messerschmidt T; Rothkegel M; Biester H; Hille R; et al. Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum-enzyme family in eukaryotes. Journal of Biological Chemistry 2010, 37847–37859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).Anantharaman V; Aravind L MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including Molybdenum cofactor sulfurases. FEMS Microbiol. Lett 2002, 207, 55–61. [DOI] [PubMed] [Google Scholar]
  • (12).Kozmin SG; Leroy P; Pavlov YI; Schaaper RM YcbX and yiiM, two novel determinants for resistance of Escherichia coli to N-hydroxylated base analogues. Mol. Microbiol 2008, 68, 51–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Llamas A; Chamizo-Ampudia A; Tejada-Jimenez M; Galvan A; Fernandez E The molybdenum cofactor enzyme mARC: Moonlighting or promiscuous enzyme? BioFactors 2017, 43 (4), 486–494. DOI: 10.1002/biof.1362 (acccessed 2019/09/18). [DOI] [PubMed] [Google Scholar]
  • (14).Yang J; Giles LJ; Ruppelt C; Mendel RR; Bittner F; Kirk ML Oxyl and Hydroxyl Radical Transfer in Mitochondrial Amidoxime Reducing Component-Catalyzed Nitrite Reduction. J. Am. Chem. Soc 2015, 137 (16), 5276–5279. DOI: 10.1021/jacs.5b01112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Ott G; Havemeyer A; Clement B The mammalian molybdenum enzymes of mARC. J. Biol. Inorg. Chem 2015, 20 (2), 265–275. DOI: 10.1007/s00775-014-1216-4. [DOI] [PubMed] [Google Scholar]
  • (16).Sparacino-Watkins CE; Tejero J. s.; Sun B; Gauthier MC; Thomas J; Ragireddy V; Merchant BA; Wang J; Azarov I; Basu P; et al. Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2. J. Biol. Chem 2014, 289 (15), 10345–10358. DOI: 10.1074/jbc.M114.555177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Krompholz N; Krischkowski C; Reichmann D; Garbe-Schonberg D; Mendel RR; Bittner F; Clement B; Havemeyer A The Mitochondrial Amidoxime Reducing Component (mARC) Is Involved in Detoxification of N-Hydroxylated Base Analogues. Chem. Res. Toxicol 2012, 25 (11), 2443–2450. DOI: 10.1021/tx300298m. [DOI] [PubMed] [Google Scholar]
  • (18).Rajapakshe A; Astashkin AV; Klein EL; Reichmann D; Mendel RR; Bittner F; Enemark JH Structural Studies of the Molybdenum Center of Mitochondrial Amidoxime Reducing Component (mARC) by Pulsed EPR Spectroscopy and O-17-Labeling. Biochemistry 2011, 50, 8813–8822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Hille R; Nishino T; Bittner F Molybdenum enzymes in higher organisms. Coord. Chem. Rev 2011, 255 (9-10), 1179–1205. DOI: 10.1016/j.ccr.2010.11.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (20).Havemeyer A; Lang JA; Clement B The fourth mammalian molybdenum enzyme mARC: current state of research. Drug Metabolism Reviews 2011, 43, 524–539. [DOI] [PubMed] [Google Scholar]
  • (21).Kozmin Stanislav G; Stepchenkova Elena I; Chow Stephen C; Schaaper Roel M A Critical Role for the Putative NCS2 Nucleobase Permease YjcD in the Sensitivity of Escherichia coli to Cytotoxic and Mutagenic Purine Analogs. mBio 2013, 4 (6), e00661–00613. DOI: 10.1128/mBio.00661-13 (acccessed 2022/11/06). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Kalimuthu P; Harmer JR; Baldauf M; Hassan AH; Kruse T; Bernhardt PV Catalytic electrochemistry of the bacterial Molybdoenzyme YcbX. Biochimica et Biophysica Acta (BBA)-Bioenergetics 2022, 1863 (7), 148579. DOI: 10.1016/j.bbabio.2022.148579. [DOI] [PubMed] [Google Scholar]
  • (23).Struwe MA; Clement B; Scheidig A Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein. Hepatology Communications 2022, 6 (11), 3277–3278, 10.1002/hep4.1984. DOI: 10.1002/hep4.1984 (acccessed 2022/11/03). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (24).Kutzler FW; Scott RA; Berg JM; Hodgson KO; Doniach S; Cramer SP; Chang CH Single-crystal polarized X-ray absorption spectroscopy. Observation and theory for (MoO2S2)2-. J. Am. Chem. Soc 1981, 103 (20), 6083–6088, Article. Scopus. [Google Scholar]
  • (25).George GN; Kipke CA; Prince RC; Sunde RA; Enemark JH; Cramer SP Structure of the Active Site of Sulfite Oxidase: X-Ray Absorption Spectroscopy of the Mo(IV), Mo(V), and Mo(VI) Oxidation States. Biochemistry 1989, 28 (12), 5075–5080. [DOI] [PubMed] [Google Scholar]
  • (26).Probst C; Yang J; Krausze J; Hercher TW; Richers CP; Spatzal T; Khadanand KC; Giles LJ; Rees DC; Mendel RR; et al. Mechanism of molybdate insertion into pterin-based molybdenum cofactors. Nature Chemistry 2021, 13 (8), 758–765. DOI: 10.1038/s41557-021-00714-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).George GN; Kipke CA; Prince RC; Sunde RA; Enemark JH; Cramer SP Structure of the Active Site of Sulfite Oxidase. X-Ray Absorption Spectroscopy of the Molybdenum (IV), Molybdenum (V), and Molybdenum (VI) Oxidation States. Biochemistry 1989, 28, 5075–5080. DOI: 10.1021/bi00438a026. [DOI] [PubMed] [Google Scholar]
  • (28).Harris HH; George GN; Rajagopalan KV High-Resolution EXAFS of the Active Site of Human Sulfite Oxidase: Comparison with Density Functional Theory and X-ray Crystallographic Results. Inorg. Chem 2006, 45, 493–495. [DOI] [PubMed] [Google Scholar]
  • (29).George GN; Pickering IJ; Kisker C X-Ray Absorption Spectroscopy of Chicken Sulfite Oxidase Crystals. Inorg. Chem 1999, 38 (10), 2539–2540. [Google Scholar]
  • (30).George GN; Garrett RM; Prince RC; Rajagopalan KV The Molybdenum Site of Sulfite Oxidase: A Comparison of Wild-Type and the Cysteine 207 to Serine Mutant using X-Ray Absorption Spectroscopy. J. Am. Chem. Soc 1996, 118 (36), 8588–8592. [Google Scholar]
  • (31).Kc K; Yang J; Kirk ML Addressing Serine Lability in a Paramagnetic Dimethyl Sulfoxide Reductase Catalytic Intermediate. Inorg. Chem 2021, 60 (13), 9233–9237. DOI: 10.1021/acs.inorgchem.1c00940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Thorp HH Bond valence sum analysis of metal-ligand bond lengths in metalloenzymes and model complexes. Inorg. Chem 1992, 31 (9), 1585–1588. DOI: 10.1021/ic00035a012. [DOI] [Google Scholar]
  • (33).George GN; Mertens JA; Campbell WH Structural Changes Induced by Catalytic Turnover at the Molybdenum Site of Arabidopsis Nitrate Reductase. J. Am. Chem. Soc 1999, 121 (41), 9730–9731. [Google Scholar]
  • (34).Pushie MJ; Doonan CJ; Moquin K; Weiner JH; Rothery R; George GN Molybdenum site structure of Escherichia coli YedY, a novel bacterial oxidoreductase. Inorg. Chem 2011, 50, 732–740. DOI: 10.1021/ic101280m. [DOI] [PubMed] [Google Scholar]
  • (35).Doonan CJ; Stockert A; Hille R; George GN Nature of the catalytically labile oxygen at the active site of xanthine oxidase. J. Am. Chem. Soc 2005, 127 (12), 4518–4522. [DOI] [PubMed] [Google Scholar]
  • (36).Tullius T; Kurtz D; Conradson S; Hodgson K Molybdenum Site of Xanthine Oxidase: Structural Evidence from X-Ray Absorption Spectroscopy. J. Am. Chem. Soc 1979, 101 (10), 2776–2779. [Google Scholar]
  • (37).Baugh PE; Garner CD; Charnock JM; Collison D; Davies ES; McAlpine AS; Bailey S; Lane I; Hanson GR; McEwan AG X-Ray Absorption Spectroscopy of Dimethylsulfoxide Reductase from Rhodobacter capsulatus. J. Biol. Inorg. Chem 1997, 2 (5), 634–643. [Google Scholar]
  • (38).Ingersol LJ; Yang J; Khadanand KC; Pokhrel A; Astashkin AV; Weiner JH; Johnston CA; Kirk ML Addressing Ligand-Based Redox in Molybdenum-Dependent Methionine Sulfoxide Reductase. J. Am. Chem. Soc 2021, 142 (6), 2721–2725. DOI: 10.1021/jacs.9b11762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).George GN X-Ray Absorption Spectroscopy of Molybdenum Enzymes. J. Biol. Inorg. Chem 1997, 2 (6), 790–796. [Google Scholar]
  • (40).Kisker C; Schindelin H; Pacheco A; Wehbi WA; Garrett RM; Rajagopalan KV; Enemark JH; Rees DC Molecular Basis of Sulfite Oxidase Deficiency from the Structure of Sulfite Oxidase. Cell 1997, 91 (7), 973–983. [DOI] [PubMed] [Google Scholar]
  • (41).Hille R Plants have SOX: The structure of sulfite oxidase from Arabidopsis thaliana. Structure 2003, 11 (10), 1189. [DOI] [PubMed] [Google Scholar]
  • (42).Schrader N; Fischer K; Theis K; Mendel RR; Schwarz G; Kisker C The crystal structure of plant sulfite oxidase provides insights into sulfite oxidation in plants and animals. Structure 2003, 11 (10), 1251. [DOI] [PubMed] [Google Scholar]
  • (43).Rudolph MJ; Johnson JL; Rajagopalan KV; Kisker C The 1.2 angstrom structure of the human sulfite oxidase cytochrome b(5) domain. Acta Crystallographica Section D-Biological Crystallography 2003, 59, 1183–1191. [DOI] [PubMed] [Google Scholar]
  • (44).Fischer K; Barbier GG; Hecht HJ; Mendel RR; Campbell WH; Schwarz G Structural basis of eukaryotic nitrate reduction: Crystal structures of the nitrate reductase active site. Plant Cell 2005, 17 (4), 1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (45).Helton M; Gruhn N; McNaughton R; Kirk M Control of oxo-molybdenum reduction and ionization potentials by dithiolate donors. Inorg. Chem 2000, 39 (11), 2273–2278. [DOI] [PubMed] [Google Scholar]
  • (46).Inscore FE; McNaughton R; Westcott BL; Helton ME; Jones R; Dhawan IK; Enemark JH; Kirk ML Spectroscopic evidence for a unique bonding interaction in oxo-molybdenum dithiolate complexes: Implications for sigma electron transfer pathways in the pyranopterin dithiolate centers of enzymes. Inorg. Chem 1999, 38 (7), 1401–1410. [Google Scholar]
  • (47).Hemann C; Hood BL; Fulton M; Hansch R; Schwarz G; Mendel RR; Kirk ML; Hille R Spectroscopic and kinetic studies of Arabidopsis thaliana sulfite oxidase: Nature of the redox-active orbital and electronic structure contributions to catalysis. J. Am. Chem. Soc 2005, 127 (47), 16567. [DOI] [PubMed] [Google Scholar]
  • (48).Caldararu O; Feldt M; Cioloboc D; van Severen MC; Starke K; Mata RA; Nordlander E; Ryde U QM/MM study of the reaction mechanism of sulfite oxidase. Scientific Reports 2018, 8. DOI: 10.1038/s41598-018-22751-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (49).van Severen MC; Andrejic M; Li JL; Starke K; Mata RA; Nordlander E; Ryde U A quantum-mechanical study of the reaction mechanism of sulfite oxidase. Journal of Biological Inorganic Chemistry 2014, 19 (7), 1165–1179. DOI: 10.1007/s00775-014-1172-z. [DOI] [PubMed] [Google Scholar]
  • (50).Xie HJ; Cao ZX Enzymatic Reduction of Nitrate to Nitrite: Insight from Density Functional Calculations. Organometallics 2010, 29 (2), 436–441. DOI: 10.1021/om9008197. [DOI] [Google Scholar]
  • (51).Holm RH; Donahue JP A Thermodynamic Scale for Oxygen Atom Transfer Reactions Polyhedron 1993, 12 (6), 571–589. DOI: 10.1016/s0277-5387(00)84972-4. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES